• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Hercules Capital Inc.

    6/20/25 4:17:16 PM ET
    $HTGC
    Investment Managers
    Finance
    Get the next $HTGC alert in real time by email
    8-K
    false 0001280784 0001280784 2025-06-18 2025-06-18 0001280784 us-gaap:CommonStockMember 2025-06-18 2025-06-18 0001280784 us-gaap:DeferrableNotesMember 2025-06-18 2025-06-18
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): June 18, 2025

     

     

    Hercules Capital, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Maryland   814-00702   74-3113410

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File No.)

     

    (I.R.S. Employer

    Identification No.)

     

    1 North B Street, Suite 2000

    San Mateo, CA

      94401
    (Address of principal executive offices)   (Zip Code)

    Registrant’s telephone number, including area code: (650) 289-3060

    Not Applicable

    (Former name or address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, par value $0.001 per share   HTGC   New York Stock Exchange
    6.25% Notes due 2033   HCXY   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.07.

    Submission of Matters to a Vote of Security Holders

    On June 18, 2025, Hercules Capital, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). As of April 17, 2025, the record date for the Annual Meeting, 175,420,455 shares of the Company’s common stock were outstanding and entitled to vote.

    The following matters were submitted at the Annual Meeting to the stockholders for consideration:

     

    Proposal 1.    Election of three directors
    Proposal 2.    Advisory vote to approve the Company’s named executive officer compensation
    Proposal 3.    Authorization of the Company to sell or issue shares of its common stock at a price below its then-current net asset value (“NAV”) per share, subject to the conditions set forth in Proposal 3
    Proposal 4.    Ratification of the selection of PricewaterhouseCoopers LLP (“PwC”) as the independent public accountant for the fiscal year ending December 31, 2025

    At the Annual Meeting, stockholders (i) elected each of Scott Bluestein, Wade Loo and DeAnne Aguirre to serve as a Class III director until 2028, or until his or her successor is elected and qualified, (ii) on an advisory basis, approved the Company’s named executive officer compensation, (iii) did not authorize the Company to sell or issue shares of its common stock at a price below its then-current NAV per share, subject to the conditions set forth in Proposal 3, and (iv) ratified the selection of PwC to serve as the Company’s independent public accountant for the year ending December 31, 2025. Detailed results are below.

     

              For    Against    Abstain    Broker Non-Votes
    Proposal 1    Scott Bluestein    63,732,497    1,111,333    1,305,121    62,194,527
       Wade Loo    61,882,801    2,636,652    1,629,498    62,194,527
       DeAnne Aguirre    53,233,934    11,628,304    1,286,713    62,194,527
              For    Against    Abstain    Broker Non-Votes
    Proposal 2       56,068,806    6,417,109    3,663,036    62,194,527
              For    Against    Abstain    Broker Non-Votes
    Proposal 3    All stockholders    52,618,130    11,069,871    2,460,950    62,194,527
       All stockholders excluding shares held by affiliates    46,991,610    11,069,871    2,460,950    62,194,527
              For    Against    Abstain    Broker Non-Votes
    Proposal 4       124,568,440    1,780,065    1,994,973    —

     

    Item 9.01.

    Financial Statements and Exhibits.

    (d) Exhibits

     

    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        HERCULES CAPITAL, INC.
    June 20, 2025    

     

      By:  

    /s/ Kiersten Zaza Botelho

           

    Kiersten Zaza Botelho

    Secretary

    Get the next $HTGC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HTGC

    DatePrice TargetRatingAnalyst
    12/12/2024$19.50 → $21.50Mkt Perform → Outperform
    Keefe Bruyette
    1/16/2024$17.00 → $17.50Buy → Neutral
    Compass Point
    11/21/2023$17.00Neutral
    UBS
    8/30/2023$17.50Neutral → Buy
    Compass Point
    8/4/2023$13.50 → $17.00Underperform → Mkt Perform
    Keefe Bruyette
    4/6/2023$16.00Neutral → Overweight
    Piper Sandler
    3/13/2023$14.50 → $10.50Mkt Perform → Underperform
    Keefe Bruyette
    7/29/2022Outperform → Perform
    Oppenheimer
    More analyst ratings